Mesenchymal cells in the treatment of spinal cord injury: Current & future perspectives

Current Stem Cell Research and Therapy

Volumn 8, Issue 1, 2013, Pages 25-38

  Vawda, Reaz ^a   Fehlings, Michael G ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Bone marrow; Cell transplantation; Clinical trial; Mesenchymal; Neural progenitor; Spinal cord injury; Umbilical cord; Wharton's jelly

Indexed keywords

ANGIOGENIC FACTOR;

ADIPOSE TISSUE; ALLOGENEIC STEM CELL TRANSPLANTATION; AMNION FLUID; AMYOTROPHIC LATERAL SCLEROSIS; ANGIOGENESIS; BONE MARROW CELL; BRAIN ISCHEMIA; CELL DIFFERENTIATION; CELL MIGRATION; CELL SURVIVAL; CELL THERAPY; CLINICAL TRIAL (TOPIC); EPITHELIUM; EX VIVO GENE TRANSFER; EXPLANT; EXTRACELLULAR MATRIX; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; LEUKEMIA; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYME CELL; MULTIPLE SCLEROSIS; NERVE CELL; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REMYELINIZATION; RETINA INJURY; REVIEW; SPINAL CORD INJURY; UMBILICAL CORD BLOOD; WHARTON JELLY;

ADULT; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; SPINAL CORD INJURIES;

EID: 84879756590     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574888X11308010005     Document Type: Review

References (240)

1. Sekhon LH, Fehlings MG. Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine (Phila Pa 1976) 2001; 26(24 Suppl): S2-12.
2. Spinal cord injury facts and figures at a glance. Birmingham, Alabama: National Spinal Cord Injury Statistical Center 2010.
3. One Degree of Separation: Paralysis and Spinal Cord Injury in the United States: Christopher and Dana Reeve Foundation 2010.
4. Spinal Cord Injury Facts and Statistics: Rick Hansen Spinal Cord Injury Registry 2006.
5. Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 1991; 75(1): 15-26.
6. Figley SA, Austin JW, Rowland JW, Fehlings MG. Pathophysiology of Spinal Cord Injury. The Cervical Spine. 5th ed: Lippincott Williams & Wilkins; 2011.
7. Vawda R, Woodbury J, Covey M, Levison SW, Mehmet H. Stem cell therapies for perinatal brain injuries. Semin Fetal Neonatal Med 2007; 12(4): 259-72.
8. Vawda R, Kennea NK, Mehmet H. Stem Cells in Neurodegeneration & Injury. In: Potten CS, Clarke RB, Wilson J, Renehan AG, editors. Tissue Stem Cells: London: Taylor & Francis Pubs 2006. p. 271-93.
9. Wang L, Shi J, van Ginkel FW, et al. Neural stem/progenitor cells modulate immune responses by suppressing T lymphocytes with nitric oxide and prostaglandin E2. Exp Neurol 2009; 216(1): 177-83.
10. Pluchino S, Gritti A, Blezer E, et al. Human neural stem cells ameliorate autoimmune encephalomyelitis in non-human primates. Ann Neurol 2009; 66(3): 343-54.
11. Okamura RM, Lebkowski J, Au M, Priest CA, Denham J, Majumdar AS. Immunological properties of human embryonic stem cell-derived oligodendrocyte progenitor cells. J Neuroimmunol 2007; 192(1-2): 134-44.
12. Bai L, Lennon DP, Eaton V, et al. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 2009; 57(11): 1192-203.
13. Jaderstad J, Jaderstad LM, Li J, et al. Communication via gap junctions underlies early functional and beneficial interactions between grafted neural stem cells and the host. Proc Natl Acad Sci USA 2010; 107(11): 5184-9.
14. Zhilai Z, Hui Z, Yinhai C, et al. Combination of NEP 1-40 infusion and bone marrow-derived neurospheres transplantation inhibit glial scar formation and promote functional recovery after rat spinal cord injury. Neurol India 2011; 59(4): 579-85.
15. Arriola A, Kiel ME, Shi Y, McKinnon RD. Adjunctive MSCs enhance myelin formation by xenogenic oligodendrocyte precursors transplanted in the retina. Cell Res 2010; 20(6): 728-31.
16. Zhang J, Wang B, Xiao Z, et al. Olfactory ensheathing cells promote proliferation and inhibit neuronal differentiation of neural progenitor cells through activation of Notch signaling. Neuroscience 2008; 153(2): 406-13.
17. Hernandeza J, Torres-Espina A, Navarro X. Adult Stem Cell Transplants for Spinal Cord Injury Repair. Current State in Preclinical Research. Curr Stem Cell Res Ther 2011; 6(3): 273-87
18. Fehlings MG, Vawda R. Cellular treatments for spinal cord injury: the time is right for clinical trials. Neurotherapeutics 2011; 8(4): 704-20.
19. Ruff CA, Fehlings MG. Neural stem cells in regenerative medicine: bridging the gap. Panminerva Med 2010; 52(2): 125-47.
20. Ruff CA, Wilcox JT, Fehlings MG. Cell-based transplantation strategies to promote plasticity following spinal cord injury. Experimental Neurology. 2011; 235(1): 78-90.
21. Gensel JC, Donnelly DJ, Popovich PG. Spinal cord injury therapies in humans: an overview of current clinical trials and their potential effects on intrinsic CNS macrophages. Expert Opin Ther Targets 2011; 15(4): 505-18.
22. Lu P, Blesch A, Tuszynski MH. Induction of bone marrow stromal cells to neurons: differentiation, transdifferentiation, or artifact? J Neurosci Res 2004; 77(2): 174-91.
23. Novikova LN, Brohlin M, Kingham PJ, Novikov LN, Wiberg M. Neuroprotective and growth-promoting effects of bone marrow stromal cells after cervical spinal cord injury in adult rats. Cytotherapy 2011; 13(7): 873-87.
24. Lu P, Jones LL, Tuszynski MH. Axon regeneration through scars and into sites of chronic spinal cord injury. Exp Neurol 2007; 203(1): 8-21.
25. Urdzikova L, Jendelova P, Glogarova K, Burian M, Hajek M, Sykova E. Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promotes recovery after spinal cord injury in rats. J Neurotrauma 2006; 23(9): 1379-91.
26. Cizkova D, Novotna I, Slovinska L, et al. Repetitive intrathecal catheter delivery of bone marrow mesenchymal stromal cells improves functional recovery in a rat model of contusive spinal cord injury. Journal of Neurotrauma 2011; 28(9): 1951-61.
27. Ohta M, Suzuki Y, Noda T, et al. Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp Neurol 2004; 187(2): 266-78.
28. Fan L, Du F, Cheng BC, Peng H, Liu SQ. Migration and distribution of bone marrow stromal cells in injured spinal cord with different transplantation techniques. Chin J Traumatol 2008; 11(2): 94-7.
29. Zurita M, Vaquero J, Bonilla C, et al. Functional recovery of chronic paraplegic pigs after autologous transplantation of bone marrow stromal cells. Transplantation 2008; 86(6): 845-53.
30. Deng YB, Liu XG, Liu ZG, Liu XL, Liu Y, Zhou GQ. Implantation of BM mesenchymal stem cells into injured spinal cord elicits de novo neurogenesis and functional recovery: evidence from a study in rhesus monkeys. Cytotherapy 2006; 8(3): 210-4.
31. Kang KN, Lee JY, Kim da Y, et al. Regeneration of Completely Transected Spinal Cord using Scaffold of Poly(D, L-lactide-coglycolide)/ Small Intestinal Submucosa seeded with rat bone marrow stem cells. Tissue Eng Part A 2011; 17(17-18): 2143-52.
32. Neuhuber B, Timothy Himes B, Shumsky JS, Gallo G, Fischer I. Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations. Brain Res 2005; 1035(1): 73-85.
33. Vaquero J, Zurita M, Oya S, Santos M. Cell therapy using bone marrow stromal cells in chronic paraplegic rats: systemic or local administration? Neurosci Lett 2006; 398(1-2): 129-34.
34. Zurita M, Vaquero J. Functional recovery in chronic paraplegia after bone marrow stromal cells transplantation. Neuroreport 2004; 15(7): 1105-8.
35. Zurita M, Vaquero J. Bone marrow stromal cells can achieve cure of chronic paraplegic rats: functional and morphological outcome one year after transplantation. Neurosci Lett 2006; 402(1-2): 51-6.
36. de Haro J, Zurita M, Ayllon L, Vaquero J. Detection of 111Inoxine-labeled bone marrow stromal cells after intravenous or intralesional administration in chronic paraplegic rats. Neurosci Lett 2005; 377(1): 7-11.
37. Kamada T, Koda M, Dezawa M, et al. Transplantation of human bone marrow stromal cell-derived Schwann cells reduces cystic cavity and promotes functional recovery after contusion injury of adult rat spinal cord. Neuropathology 2011; 31(1): 48-58.
38. Kamada T, Koda M, Dezawa M, et al. Transplantation of bone marrow stromal cell-derived Schwann cells promotes axonal regeneration and functional recovery after complete transection of adult rat spinal cord. J Neuropathol Exp Neurol 2005; 64(1): 37-45.
39. Koda M, Kamada T, Hashimoto M, et al. Adenovirus vectormediated ex vivo gene transfer of brain-derived neurotrophic factor to bone marrow stromal cells promotes axonal regeneration after transplantation in completely transected adult rat spinal cord. Eur Spine J 2007; 16(12): 2206-14.
40. Koda M, Nishio Y, Kamada T, et al. Granulocyte colonystimulating factor (G-CSF) mobilizes bone marrow-derived cells into injured spinal cord and promotes functional recovery after compression-induced spinal cord injury in mice. Brain Res 2007; 1149: 223-31.
41. Callera F, do Nascimento RX. Delivery of autologous bone marrow precursor cells into the spinal cord via lumbar puncture technique in patients with spinal cord injury: a preliminary safety study. Exp Hematol 2006; 34(2): 130-1.
42. Chernykh ER, Stupak VV, Muradov GM, et al. Application of autologous bone marrow stem cells in the therapy of spinal cord injury patients. Bull Exp Biol Med 2007; 143(4): 543-7.
43. Yoon SH, Shim YS, Park YH, et al. Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial. Stem Cells 2007; 25(8): 2066-73.
44. Saito F, Nakatani T, Iwase M, et al. Spinal cord injury treatment with intrathecal autologous bone marrow stromal cell transplantation: the first clinical trial case report. J Trauma 2008; 64(1): 53-9.
45. Bhanot Y, Rao S, Ghosh D, Balaraju S. Autologous mesenchymal stem cells in chronic spinal cord injury. Br J Neurosurg 2011; 25(4): 516-22.
46. Salgado AJ, Reis RL, Sousa NJ, Gimble JM. Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine. Curr Stem Cell Res Ther 2010; 5(2): 103-10.
47. Nakanishi C, Nagaya N, Ohnishi S, et al. Gene and protein expression analysis of mesenchymal stem cells derived from rat adipose tissue and bone marrow. Circulation Journal 2011; 75(9): 2260-8.
48. Arboleda D, Forostyak S, Jendelova P, et al. Transplantation of predifferentiated adipose-derived stromal cells for the treatment of spinal cord injury. Cell Mol Neurobiol 2011; 31(7): 1113-22.
49. Chung JY, Kim W, Im W, et al. Neuroprotective effects of adipose-derived stem cells against ischemic neuronal damage in the rabbit spinal cord. J Neurol Sci 2012; 317(1-2): 40-6.
50. Kang SK, Shin MJ, Jung JS, Kim YG, Kim CH. Autologous adipose tissue-derived stromal cells for treatment of spinal cord injury. Stem Cells Dev 2006; 15(4): 583-94.
51. Kang SK, Yeo JE, Kang KS, Phinney DG. Cytoplasmic extracts from adipose tissue stromal cells alleviates secondary damage by modulating apoptosis and promotes functional recovery following spinal cord injury. Brain Pathol 2007; 17(3): 263-75.
52. Oh JS, Ha Y, An SS, et al. Hypoxia-preconditioned adipose tissuederived mesenchymal stem cell increase the survival and gene expression of engineered neural stem cells in a spinal cord injury model. Neurosci Lett 2010; 472(3): 215-9.
53. Oh JS, Kim KN, An SS, et al. Co-transplantation of Mouse Neural Stem Sells (mNSCs) with Adipose Tissue-derived Mesenchymal Stem Sells Improves mNSC Survival in a Rat Spinal Cord Injury Model. Cell Transplant 2010; 20(6): 837-49.
54. Oh JS, Park IS, Kim KN, Yoon do H, Kim SH, Ha Y. Transplantation of an adipose stem cell cluster in a spinal cord injury. Neuroreport 2012; 23(5): 277-82.
55. Park SS, Lee YJ, Lee SH, et al. Functional recovery after spinal cord injury in dogs treated with a combination of Matrigel and neural-induced adipose-derived mesenchymal Stem cells. Cytotherapy 2012; 14(5): 584-97.
56. Ryu HH, Lim JH, Byeon YE, et al. Functional recovery and neural differentiation after transplantation of allogenic adipose-derived stem cells in a canine model of acute spinal cord injury. J Vet Sci 2009; 10(4): 273-84.
57. Zhang HT, Luo J, Sui LS, et al. Effects of differentiated versus undifferentiated adipose tissue-derived stromal cell grafts on functional recovery after spinal cord contusion. Cell Mol Neurobiol 2009; 29(8): 1283-92.
58. Mitchell KE, Weiss ML, Mitchell BM, et al. Matrix cells from Wharton's jelly form neurons and glia. Stem Cells 2003; 21(1): 50-60.
59. Wang HS, Hung SC, Peng ST, et al. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 2004; 22(7): 1330-7.
60. Weiss ML, Medicetty S, Bledsoe AR, et al. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 2006; 24(3): 781-92.
61. La Rocca G, Anzalone R, Corrao S, et al. Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochem Cell Biol 2009; 131(2): 267-82.
62. Troyer DL, Weiss ML. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 2008; 26(3): 591-9.
63. Baksh D, Yao R, Tuan RS. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem cells 2007; 25(6): 1384-92.
64. Fong CY, Chak LL, Biswas A, et al. Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. Stem Cell Rev 2011; 7(1): 1-16.
65. Fong CY, Subramanian A, Biswas A, et al. Derivation efficiency, cell proliferation, freeze-thaw survival, stem-cell properties and differentiation of human Wharton's jelly stem cells. Reprod Biomed Online 2010; 21(3): 391-401.
66. Guillot PV, De Bari C, Dell'Accio F, Kurata H, Polak J, Fisk NM. Comparative osteogenic transcription profiling of various fetal and adult mesenchymal stem cell sources. Differentiation 2008; 76(9): 946-57.
67. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004; 103(5): 1669-75.
68. Lewis ID, Verfaillie CM. Multi-lineage expansion potential of primitive hematopoietic progenitors: superiority of umbilical cord blood compared to mobilized peripheral blood. Experimental hematology Research Support, U.S. Gov't, P.H.S.] 2000; 28(9): 1087-95.
69. Lu LL, Liu YJ, Yang SG, et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesissupportive function and other potentials. Haematologica 2006; 91(8): 1017-26.
70. Mareschi K, Biasin E, Piacibello W, Aglietta M, Madon E, Fagioli F. Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood. Haematologica 2001; 86(10): 1099-100.
71. Musina RA, Bekchanova ES, Belyavskii AV, Grinenko TS, Sukhikh GT. Umbilical cord blood mesenchymal stem cells. Bulletin of experimental biology and medicine 2007; 143(1): 127-31.
72. Pappa KI, Anagnou NP. Novel sources of fetal stem cells: where do they fit on the developmental continuum? Regenerative Medicine 2009; 4(3): 423-33.
73. Secco M, Zucconi E, Vieira NM, et al. Multipotent stem cells from umbilical cord: cord is richer than blood! Stem cells 2008; 26(1): 146-50.
74. Wexler SA, Donaldson C, Denning-Kendall P, Rice C, Bradley B, Hows JM. Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not. British Journal of Haematology 2003; 121(2): 368-74.
75. Zeddou M, Briquet A, Relic B, et al. The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood. Cell Biology Int 2010; 34(7): 693-701.
76. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 2001; 98(8): 2396-402.
77. Fong CY, Subramanian A, Biswas A, et al. Derivation efficiency, cell proliferation, freeze-thaw survival, stem-cell properties and differentiation of human Wharton's jelly stem cells. Reproductive Biomedicine online 2010; 21(3): 391-401.
78. Medicetty S, Bledsoe AR, Fahrenholtz CB, Troyer D, Weiss ML. Transplantation of pig stem cells into rat brain: proliferation during the first 8 weeks. Experimental Neurology. 2004; 190(1): 32-41.
79. Bruder SP, Fink DJ, Caplan AI. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem [Research Support, U.S. Gov't, P.H.S. Review] 1994 56(3): 283-94.
80. Caplan AI. The mesengenic process. Clin Plast Surg [Research Support, U.S. Gov't, P.H.S. Review] 1994; 21(3): 429-35.
81. Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 2005; 23(2): 220-9.
82. Karahuseyinoglu S, Cinar O, Kilic E, et al. Biology of stem cells in human umbilical cord stroma: in situ and in vivo surveys. Stem Cells 2007; 25(2): 319-31.
83. Manca MF, Zwart I, Beo J, et al. Characterization of mesenchymal stromal cells derived from full-term umbilical cord blood. Cytotherapy 2008; 10(1): 54-68.
84. Gluckman E, Rocha V, Chastang C. Peripheral stem cells in bone marrow transplantation. Cord blood stem cell transplantation. Baillieres Best Pract Res Clin Haematol 1999; 12(1-2): 279-92.
85. Weiss ML, Anderson C, Medicetty S, et al. Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells 2008; 26(11): 2865-74.
86. Weiss ML, Mitchell KE, Hix JE, et al. Transplantation of porcine umbilical cord matrix cells into the rat brain. Exp Neurol 2003; 182(2): 288-99.
87. Lund RD, Wang S, Lu B, et al. Cells isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease. Stem Cells 2007; 25(3): 602-11.
88. Szegezdi E, O'Reilly A, Davy Y, Vawda R, et al. Stem cells are resistant to TRAIL receptor-mediated apoptosis. J Cell Mol Med 2009; 13(11-12): 4409-14.
89. Fong CY, Gauthaman K, Bongso A. Teratomas from pluripotent stem cells: A clinical hurdle. J Cell Biochem 2010; 111(4): 769-81.
90. Ayuzawa R, Doi C, Rachakatla RS, et al. Naive human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vivo and in vivo. Cancer Lett 2009; 280(1): 31-7.
91. Ganta C, Chiyo D, Ayuzawa R, et al. Rat umbilical cord stem cells completely abolish rat mammary carcinomas with no evidence of metastasis or recurrence 100 days post-tumor cell inoculation. Cancer Res 2009; 69(5): 1815-20.
92. Montanucci P, Basta G, Pescara T, Pennoni I, Di Giovanni F, Calafiore R. New simple and rapid method for purification of mesenchymal stem cells from the human umbilical cord Wharton jelly. Tissue Eng Part A 2011; 17(21-22): 2651-61.
93. Tong CK, Vellasamy S, Tan BC, et al. Generation of mesenchymal stem cell from human umbilical cord tissue using a combination enzymatic and mechanical disassociation method. Cell biology Int 2011; 35(3): 221-6.
94. Hodgkinson CP, Gomez JA, Mirotsou M, Dzau VJ. Genetic engineering of mesenchymal stem cells and its application in human disease therapy. Hum Gene Ther [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review] 2010; 21(11): 1513-26.
95. Porada CD, Almeida-Porada G. Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery. Advanced Drug Delivery Reviews 2010; 62(12): 1156-66.
96. Ersek A, Pixley JS, Goodrich AD, et al. Persistent circulating human insulin in sheep transplanted in utero with human mesenchymal stem cells. Experimental Hematology [Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.] 2010; 38(4): 311-20.
97. Lim JY, Park SH, Jeong CH, et al. Microporation is a valuable transfection method for efficient gene delivery into human umbilical cord blood-derived mesenchymal stem cells. BMC Biotechnology 2010; 10: 38.
98. Park SA, Ryu CH, Kim SM, et al. CXCR4-transfected human umbilical cord blood-derived mesenchymal stem cells exhibit enhanced migratory capacity toward gliomas. Int J Oncol 2011; 38(1): 97-103.
99. Shang AJ, Hong SQ, Xu Q, et al. NT-3-secreting human umbilical cord mesenchymal stromal cell transplantation for the treatment of acute spinal cord injury in rats. Brain Res 2011; 1391: 102-13.
100. Kermani AJ, Fathi F, Mowla SJ. Characterization and genetic manipulation of human umbilical cord vein mesenchymal stem cells: potential application in cell-based gene therapy. Rejuvenation Res 2008; 11(2): 379-86.
101. Ryu CH, Park SH, Park SA, et al. Gene therapy of intracranial glioma using interleukin 12-secreting human umbilical cord bloodderived mesenchymal stem cells. Hum Gene Ther 2011; 22(6): 733-43.
102. Friedman R, Betancur M, Boissel L, Tuncer H, Cetrulo C, Klingemann H. Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation. Biol Blood Marrow Transplant 2007; 13(12): 1477-86.
103. Klingemann H, inventor. Methods for preparing cord matrix stem cells (CMSC) for long-term storage and for preparing a segment of umbilical cord for cryopreservation. Patent US20090170059 2009.
104. Ennis J, Sarugaser R, Davies JE, inventors. Viable cells from frozen umbilical cord tissue. Patent US20090275127 2009.
105. Carvalho MM, Teixeira FG, Reis RL, Sousa N, Salgado AJ. Mesenchymal stem cells in the umbilical cord: phenotypic characterization, secretome and applications in central nervous system regenerative medicine. Curr Stem Cell Res Ther 2011; 6(3): 221-8.
106. Dalous J, Larghero J, Baud O. Transplantation of umbilical cordderived mesenchymal stem cells as a novel strategy to protect the central nervous system: technical aspects, preclinical studies, and clinical perspectives. Pediatr Res 2012; 71(4 Pt 2): 482-90.
107. Yang CC, Shih YH, Ko MH, Hsu SY, Cheng H, Fu YS. Transplantation of human umbilical mesenchymal stem cells from Wharton's jelly after complete transection of the rat spinal cord. PLoS ONE 2008; 3(10): e3336.
108. Zhang L, Zhang HT, Hong SQ, Ma X, Jiang XD, Xu RX. Cografted Wharton's Jelly Cells-derived Neurospheres and BDNF Promote Functional Recovery After Rat Spinal Cord Transection. Neurochem Res 2009; 34(11): 2030-9.
109. Hu SL, Luo HS, Li JT, et al. Functional recovery in acute traumatic spinal cord injury after transplantation of human umbilical cord mesenchymal stem cells. Crit Care Med 2010; 38(11): 2181-9.
110. Shang AJ, Hong SQ, Xu Q, et al. NT-3-secreting human umbilical cord mesenchymal stromal cell transplantation for the treatment of acute spinal cord injury in rats. Brain Res 2011; 1391: 102-13.
111. Yan-Wu G, Yi-Quan K, Ming L, et al. Human umbilical cordderived schwann-like cell transplantation combined with neurotrophin-3 administration in dyskinesia of rats with spinal cord injury. Neurochem Res 2011; 36(5): 783-92.
112. Zhilai Z, Hui Z, Anmin J, Shaoxiong M, Bo Y, Yinhai C. A combination of taxol infusion and human umbilical cord mesenchymal stem cells transplantation for the treatment of rat spinal cord injury. Brain Res 2012; 1481: 79-89.
113. Fu YS, inventor. Treatment of spinal injuries using human umbilical mesenchymal stem cells. Patent US20080305148 2008.
114. Park DH, Lee JH, Borlongan CV, Sanberg PR, Chung YG, Cho TH. Transplantation of umbilical cord blood stem cells for treating spinal cord injury. Stem Cell Rev 2011; 7(1): 181-94.
115. Park SS, Byeon YE, Ryu HH, et al. Comparison of canine umbilical cord blood-derived mesenchymal stem cell transplantation times: Involvement of astrogliosis, inflammation, intracellular actin cytoskeleton pathways, and neurotrophin. Cell Transplant 2011; 20(11-12): 1867-80.
116. Schira J, Gasis M, Estrada V, et al. Significant clinical, neuropathological and behavioural recovery from acute spinal cord trauma by transplantation of a well-defined somatic stem cell from human umbilical cord blood. Brain 2012; 135(Pt 2): 431-46.
117. Le Blanc K, Gotherstrom C, Ringden O, et al. Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 2005; 79(11): 1607-14.
118. Macias MI, Grande J, Moreno A, Dominguez I, Bornstein R, Flores AI. Isolation and characterization of true mesenchymal stem cells derived from human term decidua capable of multilineage differentiation into all 3 embryonic layers. Am J Obstet Gynecol 2010; 203(5): 495 e9-e23.
119. Barberi T, Willis LM, Socci ND, Studer L. Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med 2005; 2(6): e161.
120. Boyd NL, Nunes SS, Jokinen JD, et al. Microvascular mural cell functionality of human embryonic stem cell-derived mesenchymal cells. Tissue Eng Part A 2011; 17(11-12): 1537-48.
121. Boyd NL, Nunes SS, Krishnan L, et al. Dissecting the Role of Human Embryonic Stem Cell-Derived Mesenchymal Cells in Human Umbilical Vein Endothelial Cell Network Stabilization in Three-Dimensional Environments. Tissue Eng Part A 2012; 19(1-2): 211-23.
122. Boyd NL, Robbins KR, Dhara SK, West FD, Stice SL. Human embryonic stem cell-derived mesoderm-like epithelium transitions to mesenchymal progenitor cells. Tissue Eng Part A 2009; 15(8): 1897-907.
123. Choo A, Lim SK. Derivation of mesenchymal stem cells from human embryonic stem cells. Methods Mol Biol 2011; 690: 175-82.
124. Giuliani M, Oudrhiri N, Noman ZM, et al. Human mesenchymal stem cells derived from induced pluripotent stem cells downregulate NK-cell cytolytic machinery. Blood 2011; 118(12): 3254-62.
125. Gruenloh W, Kambal A, Sondergaard C, et al. Characterization and in vivo testing of mesenchymal stem cells derived from human embryonic stem cells. Tissue Eng Part A 2011; 17(11-12): 1517-25.
126. Hematti P. Human embryonic stem cell-derived mesenchymal stromal cells. Transfusion 2011; 51 Suppl 4: 138S-44S.
127. Hematti P. Human embryonic stem cell-derived mesenchymal progenitors: an overview. Methods Mol Biol 2011; 690: 163-74.
128. Karlsson C, Emanuelsson K, Wessberg F, et al. Human embryonic stem cell-derived mesenchymal progenitors-Potential in regenerative medicine. Stem Cell Res 2009; 3(1): 39-50.
129. Lian Q, Zhang Y, Zhang J, et al. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation 2010; 121(9): 1113-23.
130. Olivier EN, Bouhassira EE. Differentiation of human embryonic stem cells into mesenchymal stem cells by the "raclure" method. Methods Mol Biol 2011; 690: 183-93.
131. Olivier EN, Rybicki AC, Bouhassira EE. Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells. Stem Cells 2006; 24(8): 1914-22.
132. Trivedi P, Hematti P. Simultaneous generation of CD34+ primitive hematopoietic cells and CD73+ mesenchymal stem cells from human embryonic stem cells cocultured with murine OP9 stromal cells. Exp Hematol 2007; 35(1): 146-54.
133. Trivedi P, Hematti P. Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells. Exp Hematol 2008; 36(3): 350-9.
134. Brown SE, Tong W, Krebsbach PH. The derivation of mesenchymal stem cells from human embryonic stem cells. Cells Tissues Organs 2009; 189(1-4): 256-60.
135. Hwang NS, Varghese S, Lee HJ, et al. In vivo commitment and functional tissue regeneration using human embryonic stem cellderived mesenchymal cells. Proc Natl Acad Sci USA 2008; 105(52): 20641-6.
136. Laurila JP, Laatikainen L, Castellone MD, et al. Human embryonic stem cell-derived mesenchymal stromal cell transplantation in a rat hind limb injury model. Cytotherapy 2009; 11(6): 726-37.
137. Lee EJ, Lee HN, Kang HJ, et al. Novel embryoid body-based method to derive mesenchymal stem cells from human embryonic stem cells. Tissue Eng Part A 2010; 16(2): 705-15.
138. Mahmood A, Harkness L, Schroder HD, Abdallah BM, Kassem M. Enhanced differentiation of human embryonic stem cells to mesenchymal progenitors by inhibition of TGF-beta/activin/nodal signaling using SB-431542. J Bone Miner Res 2010; 25(6): 1216-33.
139. Roche S, Delorme B, Oostendorp RA, et al. Comparative proteomic analysis of human mesenchymal and embryonic stem cells: towards the definition of a mesenchymal stem cell proteomic signature. Proteomics 2009; 9(2): 223-32.
140. Sze SK, de Kleijn DP, Lai RC, et al. Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells. Mol Cell Proteomics 2007; 6(10): 1680-9.
141. Teramura T, Onodera Y, Mihara T, Hosoi Y, Hamanishi C, Fukuda K. Induction of mesenchymal progenitor cells with chondrogenic property from mouse-induced pluripotent stem cells. Cell Reprogram 2010; 12(3): 249-61.
142. Lee EJ, Xu L, Kim GH, et al. Regeneration of peripheral nerves by transplanted sphere of human mesenchymal stem cells derived from embryonic stem cells. Biomaterials 2012; 33(29): 7039-46.
143. Fehlings MG, Vawda R. Cellular treatments for spinal cord injury: the time is right for clinical trials. Neurotherapeutics 2011; 8(4): 704-20.
144. Prusa AR, Hengstschlager M. Amniotic fluid cells and human stem cell research: a new connection. Med Sci Monit 2002; 8(11): RA253-7.
145. Roubelakis MG, Trohatou O, Anagnou NP. Amniotic fluid and amniotic membrane stem cells: marker discovery. Stem Cells Int 2012: 107836.
146. Tsai MS, Hwang SM, Chen KD, et al. Functional network analysis of the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow. Stem Cells 2007; 25(10): 2511-23.
147. Tsai MS, Lee JL, Chang YJ, Hwang SM. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Human Reproduction 2004; 19(6): 1450-6.
148. In't Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood [Letter] 2003; 102(4): 1548-9.
149. Alviano F, Fossati V, Marchionni C, et al. Term Amniotic membrane is a high throughput source for multipotent Mesenchymal Stem Cells with the ability to differentiate into endothelial cells in vivo. BMC Dev Biol 2007; 7: 11.
150. Tsai MS, Hwang SM, Tsai YL, Cheng FC, Lee JL, Chang YJ. Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells. Biol Reprod 2006; 74(3): 545-51.
151. De Coppi P, Bartsch G, Jr., Siddiqui MM, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007; 25(1): 100-6.
152. Wu ZY, Hui GZ, Lu Y, Wu X, Guo LH. Transplantation of human amniotic epithelial cells improves hindlimb function in rats with spinal cord injury. Chin Med J (Engl) 2006; 119(24): 2101-7.
153. Xue H, Zhang XY, Liu JM, Song Y, Li YF, Chen D. Development of a chemically extracted acellular muscle scaffold seeded with amniotic epithelial cells to promote spinal cord repair. J Biomed Mater Res A 2012; 101(1): 145-56.
154. Solomon A, Wajngarten M, Alviano F, et al. Suppression of inflammatory and fibrotic responses in allergic inflammation by the amniotic membrane stromal matrix. Clin Exp Allergy 2005; 35(7): 941-8.
155. Sankar V, Muthusamy R. Role of human amniotic epithelial cell transplantation in spinal cord injury repair research. Neuroscience 2003; 118(1): 11-7.
156. Meng XT, Li C, Dong ZY, et al. Co-transplantation of bFGFexpressing amniotic epithelial cells and neural stem cells promotes functional recovery in spinal cord-injured rats. Cell Biol Int 2008; 32(12): 1546-58.
157. Venkatachalam S, Palaniappan T, Jayapal PK, Neelamegan S, Rajan SS, Muthiah VP. Novel neurotrophic factor secreted by amniotic epithelial cells. Biocell 2009; 33(2): 81-9.
158. Mujezinovic F, Alfirevic Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol 2007; 110(3): 687-94.
159. Freedman MS, Bar-Or A, Atkins HL, et al. The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group. Mult Scler 2010; 16(4): 503-10.
160. Ryu HH, Kang BJ, Park SS, et al. Comparison of Mesenchymal Stem Cells Derived from Fat, Bone Marrow, Wharton's Jelly, and Umbilical Cord Blood for Treating Spinal Cord Injuries in Dogs. J Vet Med Sci 2012; 74(12): 1617-1630.
161. Tan Z, Su ZY, Wu RR, et al. Immunomodulative effects of mesenchymal stem cells derived from human embryonic stem cells in vivo and in vivo. J Zhejiang Univ Sci B 2011; 12(1): 18-27.
162. Yen BL, Chang CJ, Liu KJ, et al. Brief report--human embryonic stem cell-derived mesenchymal progenitors possess strong immunosuppressive effects toward natural killer cells as well as T lymphocytes. Stem Cells 2009; 27(2): 451-6.
163. One Degree of Separation: Paralysis and Spinal Cord Injury in the United States. 2010.
164. Boido M, Garbossa D, Fontanella M, Ducati A, Vercelli A. Mesenchymal stem cell transplantation reduces glial cyst and improves functional outcome following spinal cord compression. World Neurosurg 2012; PII: S1878-8750(12)00908-4.
165. Busch SA, Hamilton JA, Horn KP, et al. Multipotent adult progenitor cells prevent macrophage-mediated axonal dieback and promote regrowth after spinal cord injury. J Neurosci 2011; 31(3): 944-53.
166. Rodrigues LP, Iglesias D, Nicola FC, et al. Transplantation of mononuclear cells from human umbilical cord blood promotes functional recovery after traumatic spinal cord injury in Wistar rats. Braz J Med Biol Res 2012; 45(1): 49-57.
167. Park SI, Lim JY, Jeong CH, et al. Human umbilical cord bloodderived mesenchymal stem cell therapy promotes functional recovery of contused rat spinal cord through enhancement of endogenous cell proliferation and oligogenesis. J Biomed Biotechnol 2012; 2012: 362473.
168. Lee JH, Chung WH, Kang EH, et al. Schwann cell-like remyelination following transplantation of human umbilical cord blood (hUCB)-derived mesenchymal stem cells in dogs with acute spinal cord injury. J Neurol Sci 2011; 300(1-2): 86-96.
169. Sarojini H, Estrada R, Lu H, et al. PEDF from mouse mesenchymal stem cell secretome attracts fibroblasts. J Cell Biochem 2008; 104(5): 1793-802.
170. Hawryluk GW, Fehlings MG. The center of the spinal cord may be central to its repair. Cell Stem Cell 2008; 3(3): 230-2.
171. Martens DJ, Seaberg RM, van der Kooy D. In vivo infusions of exogenous growth factors into the fourth ventricle of the adult mouse brain increase the proliferation of neural progenitors around the fourth ventricle and the central canal of the spinal cord. Eur J Neurosci 2002; 16(6): 1045-57.
172. Meletis K, Barnabe-Heider F, Carlen M, et al. Spinal cord injury reveals multilineage differentiation of ependymal cells. PLoS Biol 2008; 6(7): e182.
173. Yamamoto S, Yamamoto N, Kitamura T, Nakamura K, Nakafuku M. Proliferation of parenchymal neural progenitors in response to injury in the adult rat spinal cord. Exp Neurol 2001; 172(1): 115-27.
174. Oskowitz A, McFerrin H, Gutschow M, Carter ML, Pochampally R. Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic. Stem Cell Res 2011; 6(3): 215-25.
175. Semenza GL. Vasculogenesis, angiogenesis, and arteriogenesis: mechanisms of blood vessel formation and remodeling. J Cell Biochem 2007; 102(4): 840-7.
176. Buschmann I, Schaper W. Arteriogenesis Versus Angiogenesis: Two Mechanisms of Vessel Growth. News Physiol Sci 1999; 14: 121-5.
177. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000; 6(4): 389-95.
178. Glaser J, Gonzalez R, Perreau VM, Cotman CW, Keirstead HS. Neutralization of the chemokine CXCL10 enhances tissue sparing and angiogenesis following spinal cord injury. J Neurosci Res 2004; 77(5): 701-8.
179. Glaser J, Gonzalez R, Sadr E, Keirstead HS. Neutralization of the chemokine CXCL10 reduces apoptosis and increases axon sprouting after spinal cord injury. J Neurosci Res 2006; 84(4): 724-34.
180. Kaneko S, Iwanami A, Nakamura M, et al. A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord. Nat Med 2006; 12(12): 1380-9.
181. Yoshihara T, Ohta M, Itokazu Y, et al. Neuroprotective effect of bone marrow-derived mononuclear cells promoting functional recovery from spinal cord injury. J Neurotrauma 2007; 24(6): 1026-36.
182. Hou S, Xu Q, Tian W, et al. The repair of brain lesion by implantation of hyaluronic acid hydrogels modified with laminin. Journal of Neuroscience Methods 2005; 148(1): 60-70.
183. Ohab JJ, Fleming S, Blesch A, Carmichael ST. A neurovascular niche for neurogenesis after stroke. J Neurosci Research Support, N.I.H., Extramural 2006; 26(50): 13007-16.
184. Peters MC, Polverini PJ, Mooney DJ. Engineering vascular networks in porous polymer matrices. Journal of Biomedical Materials Research. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.] 2002; 60(4): 668-78.
185. Raab S, Plate KH. Different networks, common growth factors: shared growth factors and receptors of the vascular and the nervous system. Acta Neuropathologica 2007; 113(6): 607-26.
186. Bearden SE, Segal SS. Neurovascular alignment in adult mouse skeletal muscles. Microcirculation [Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.] 2005; 12(2): 161-7.
187. Mirabella T, Cilli M, Carlone S, Cancedda R, Gentili C. Amniotic liquid derived stem cells as reservoir of secreted angiogenic factors capable of stimulating neo-arteriogenesis in an ischemic model. Biomaterials 2011; 32(15): 3689-99.
188. Mirabella T, Hartinger J, Lorandi C, Gentili C, van Griensven M, Cancedda R. Proangiogenic soluble factors from amniotic fluid stem cells mediate the recruitment of endothelial progenitors in a model of ischemic fasciocutaneous flap. Stem Cells Dev 2012; 21(12): 2179-88.
189. Alexanian AR, Fehlings MG, Zhang Z, Maiman DJ. Transplanted neurally modified bone marrow-derived mesenchymal stem cells promote tissue protection and locomotor recovery in spinal cord injured rats. Neurorehabil Neural Repair 2011; 25(9): 873-80.
190. Choi CI, Lee YD, Kim H, Kim SH, Suh-Kim H, Kim SS. Neural Induction with Neurogenin 1 Enhances the Therapeutic Potential of Mesenchymal Stem Cells in an ALS Mouse Model. Cell Transplant. 2012; 26(9): 2217-28.
191. Chuang TJ, Lin KC, Chio CC, Wang CC, Chang CP, Kuo JR. Effects of secretome obtained from normoxia-preconditioned human mesenchymal stem cells in traumatic brain injury rats. J Trauma Acute Care Surg 2012; 73(5): 1161-7.
192. Skalnikova H, Motlik J, Gadher SJ, Kovarova H. Mapping of the secretome of primary isolates of mammalian cells, stem cells and derived cell lines. Proteomics 2011; 11(4): 691-708.
193. Blankley RT, Robinson NJ, Aplin JD, et al. A gel-free quantitative proteomics analysis of factors released from hypoxic-conditioned placentae. Reprod Sci 2010; 17(3): 247-57.
194. Wang Y, Bakota E, Chang BH, Entman M, Hartgerink JD, Danesh FR. Peptide nanofibers preconditioned with stem cell secretome are renoprotective. J Am Soc Nephrol 2011; 22(4): 704-17.
195. Baglio SR, Pegtel DM, Baldini N. Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy. Front Physiol 2012; 3: 359.
196. Ribeiro CA, Salgado AJ, Fraga JS, Silva NA, Reis RL, Sousa N. The secretome of bone marrow mesenchymal stem cellsconditioned media varies with time and drives a distinct effect on mature neurons and glial cells (primary cultures). J Tissue Eng Regen Med 2011; 5(8): 668-72.
197. Ribeiro CA, Fraga JS, Graos M, et al. The secretome of stem cells isolated from the adipose tissue and Wharton jelly acts differently on central nervous system derived cell populations. Stem Cell Research & Therapy 2012; 3(3): 18.
198. Roche S, D'Ippolito G, Gomez LA, et al. Comparative analysis of protein expression of three stem cell populations: Models of cytokine delivery system in vivo. Int J Pharm 2012; 440(1): 72-82.
199. Zvonic S, Lefevre M, Kilroy G, et al. Secretome of primary cultures of human adipose-derived stem cells: modulation of serpins by adipogenesis. Mol Cell Proteomics 2007; 6(1): 18-28.
200. Salgado AJ, Reis RL, Sousa NJ, Gimble JM. Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine. Curr Stem Cell Res Ther 2010; 5(2): 103-10.
201. Kwon BK, Hillyer J, Tetzlaff W. Translational research in spinal cord injury: a survey of opinion from the SCI community. J Neurotrauma 2010; 27(1): 21-33.
202. Kwon BK, Sekhon LH, Fehlings MG. Emerging repair, regeneration, and translational research advances for spinal cord injury. Spine (Phila Pa 1976) 2010; 35(21 Suppl): S263-70.
203. Tetzlaff W, Okon EB, Karimi-Abdolrezaee S, et al. A Systematic Review of Cellular Transplantation Therapies for Spinal Cord Injury. J Neurotrauma 2010; 28(8): 1611-82.
204. Duvdevani R, Rosner M, Belkin M, Sautter J, Sabel BA, Schwartz M. Graded crush of the rat optic nerve as a brain injury model: combining electrophysiological and behavioral outcome. Restorative Neurology and Neuroscience 1990; 2(1): 31-8.
205. Sagot Y, Swerts JP, Cochard P. Changes in permissivity for neuronal attachment and neurite outgrowth of spinal cord grey and white matters during development: a study with the 'cryoculture' bioassay. Brain Res 1991; 543(1): 25-35.
206. Mouveroux JM, Lakke EA, Marani E. Intrinsic properties inhibit axonal outgrowth from neonatal rat spinal cord explant. Archives of Physiology and Biochemistry 2002; 110(3): 177-85.
207. Kuang RZ, Merline M, Kalil K. Topographic specificity of corticospinal connections formed in explant coculture. Development [Research Support, U.S. Gov't, P.H.S.] 1994; 120(7): 1937-47.
208. Casha S, Yu WR, Fehlings MG. FAS deficiency reduces apoptosis, spares axons and improves function after spinal cord injury. Exp Neurol 2005; 196(2): 390-400.
209. Pipes BL, Ablin RJ. Embryonic stem cell co-transplantation revisited: utility of umbilical cord blood "embryonic-like" stem cells. Annals of Clinical and Laboratory Science [Comment Letter] 2006; 36(1): 105-6.
210. Heng BC, Liu H, Cao T. Potential benefits of co-transplanting autologous adult stem cells together with human embryonic stem cells or their differentiated derivatives. Annals of Clinical and Laboratory Science [Editorial Review] 2005; 35(1): 3-6.
211. Puymirat E, Geha R, Tomescot A, et al. Can mesenchymal stem cells induce tolerance to cotransplanted human embryonic stem cells? Mol Ther 2009; 17(1): 176-82.
212. Ikegami T, Nakamura M, Yamane J, et al. Chondroitinase ABC combined with neural stem/progenitor cell transplantation enhances graft cell migration and outgrowth of growth-associated protein-43-positive fibers after rat spinal cord injury. Eur J Neurosci 2005; 22(12): 3036-46.
213. Karimi-Abdolrezaee S, Eftekharpour E, Wang J, Schut D, Fehlings MG. Synergistic effects of transplanted adult neural stem/progenitor cells, chondroitinase, and growth factors promote functional repair and plasticity of the chronically injured spinal cord. J Neurosci 2010; 30(5): 1657-76.
214. Edgerton VR, Kim SJ, Ichiyama RM, Gerasimenko YP, Roy RR. Rehabilitative therapies after spinal cord injury. J Neurotrauma 2006; 23(3-4): 560-70.
215. Engesser-Cesar C, Anderson AJ, Basso DM, Edgerton VR, Cotman CW. Voluntary wheel running improves recovery from a moderate spinal cord injury. J Neurotrauma 2005; 22(1): 157-71.
216. Barbeau H, Rossignol S. Enhancement of locomotor recovery following spinal cord injury. Current Opinion in Neurology 1994; 7(6): 517-24.
217. Raineteau O, Schwab ME. Plasticity of motor systems after incomplete spinal cord injury. Nat Rev Neurosci 2001; 2(4): 263-73.
218. Bouyer LJ. Animal models for studying potential training strategies in persons with spinal cord injury. JNPT 2005; 29(3): 117-25.
219. Nash MS. Exercise as a health-promoting activity following spinal cord injury. JNPT 2005; 29: 87-103.
220. Wernig A. Long-term body-weight supported treadmill training and subsequent follow-up in persons with chronic SCI: effects on functional walking ability and measures of subjective well-being. Spinal Cord [Comment Letter] 2006; 44: 265-6; author reply 7-8.
221. Yoshihara H, Shumsky JS, Neuhuber B, Otsuka T, Fischer I, Murray M. Combining motor training with transplantation of rat bone marrow stromal cells does not improve repair or recovery in rats with thoracic contusion injuries. Brain Res 2006; 1119: 65-75.
222. Atkins H, Freedman M. Immune ablation followed by autologous hematopoietic stem cell transplantation for the treatment of poor prognosis multiple sclerosis. Methods Mol Bio 2009; 549: 231-46.
223. Liu YH, Vaghjiani V, Tee JY, et al. Amniotic epithelial cells from the human placenta potently suppress a mouse model of multiple sclerosis. PLoS One 2012; 7: e35758.
224. Bai L, Lennon DP, Caplan AI, et al. Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models. Nat Neurosci 2012; 15: 862-70.
225. Blanquer M, Moraleda JM, Iniesta F, et al. Neurotrophic bone marrow cellular nests prevent spinal motoneuron degeneration in amyotrophic lateral sclerosis patients: a pilot safety study. Stem Cells 2012; 30: 1277-85.
226. Cordes AL, Jahn K, Hass R, et al. Intramedullary spinal cord implantation of human CD34+ umbilical cord-derived cells in ALS. Amyotroph Lateral Scler 2011; 12: 325-30.
227. Knippenberg S, Thau N, Schwabe K, et al. Intraspinal injection of human umbilical cord blood-derived cells is neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis. Neurodegener Dis 2012; 9: 107-20.
228. Garbuzova-Davis S, Rodrigues MC, Mirtyl S, et al. Multiple intravenous administrations of human umbilical cord blood cells benefit in a mouse model of ALS. PLoS One 2012; 7: e31254.
229. Bigini P, Veglianese P, Andriolo G, et al. Intracerebroventricular administration of human umbilical cord blood cells delays disease progression in two murine models of motor neuron degeneration. Rejuvenation Res 2011; 14: 623-39.
230. Lim JY, Jeong CH, Jun JA, et al. Therapeutic effects of human umbilical cord blood-derived mesenchymal stem cells after intrathecal administration by lumbar puncture in a rat model of cerebral ischemia. Stem Cell Res Ther 2011; 2: 38.
231. Liu YP, Seckin H, Izci Y, Du ZW, Yan YP, Baskaya MK. Neuroprotective effects of mesenchymal stem cells derived from human embryonic stem cells in transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab 2009; 29: 780-91.
232. Zhang L, Li Y, Zhang C, Chopp M, Gosiewska A, Hong K. Delayed administration of human umbilical tissue-derived cells improved neurological functional recovery in a rodent model of focal ischemia. Stroke 2011; 42: 1437-44.
233. Koh SH, Kim KS, Choi MR, et al. Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Brain Res 2008; 1229: 233-48.
234. Xia G, Hong X, Chen X, Lan F, Zhang G, Liao L. Intracerebral transplantation of mesenchymal stem cells derived from human umbilical cord blood alleviates hypoxic ischemic brain injury in rat neonates. Journal of perinatal medicine 2010; 38: 215-21.
235. Ding DC, Shyu WC, Chiang MF, et al. Enhancement of neuroplasticity through upregulation of beta1-integrin in human umbilical cord-derived stromal cell implanted stroke model. Neurobiol Dis 2007; 27: 339-53.
236. Liao W, Zhong J, Yu J, et al. Therapeutic benefit of human umbilical cord derived mesenchymal stromal cells in intracerebral hemorrhage rat: implications of anti-inflammation and angiogenesis. Cell Physiol Biochem 2009; 24: 307-16.
237. Chang CP, Chio CC, Cheong CU, Chao CM, Cheng BC, Lin MT. Hypoxic preconditioning enhances the therapeutic potential of secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury. Clin Sci (Lond) 2012; 124(3): 165-76.
238. Anzalone R, Farina F, Zummo G, La Rocca G. Recent patents and Advances on Isolation and Cellular Therapy Applications of Mesenchymal Stem Cells from Human Umbilical Cord Wharton's Jelly. Recent Patents on Regenerative Medicine 2011; 1: 215-27.
239. Li H, Shyu WC, Ding DC, Lin SZ, inventors. Brain tissue damage therapies. US7923007 2011.
240. Fu, Y. S, inventor. Method for treating brain ischemic injury through transplantation of human mesenchymal stem cells. US20090232782 2009.